Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2014

May 13, 2014

32044_dirs_2014-05-13_33855c47-1b3c-4607-8b7b-194074a6d8fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2014-05-13

Reporting Person: Reed Thomas D. (Director, Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-13 Common Stock P 640 $15.60 Acquired 2440 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 79340 Indirect
Common Stock 253005 Indirect

Footnotes

F1: Held by Jacquelyn Ann Reed, spouse.

F2: Held by Thomas David Reed, Trustee of the Thomas David Reed Living Trust dated February 4, 2011.

F3: Held by Jacquelyn Ann Reed, Trustee of the Jacquelyn Ann Reed Living Trust dated Febrary 4, 2011.